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3,4-Disubstituted  -lactams  3-benzyloxy-4-(4-chlorophenyl)azetidin-2-one  [(3S*,4R*)-(±)-1],  3-
benzyloxy-4-phenylazetidin-2-one  [(3S*,4R*)-(±)-2]  and  4-(4-chlorophenyl)-3-phenoxyazetidin-2-one
[(3S*,4R*)-(±)-3]  were  resolved  through  immobilized  CAL-B-catalysed  ring-cleavage  reactions.  Excellent
enantioselectivities  (E >  200)  were  obtained  for  (3S*,4R*)-(±)-1  and  (3S*,4R*)-(±)-2  when  the  reactions
were  performed  with added  H O as nucleophile  in  tert-butyl  methyl  ether  at 70 ◦C, whereas  onlyeywords:
andida antarctica lipase B
ing-cleavage
nzyme catalysis
axol
2
moderate  E (12)  was  achieved  for  (3S*,4R*)-(±)-3  under  the  same  conditions  but  in diisopropyl  ether.  The
resulting  ring-opened  -amino  acids  [(2R,3S)-4  (ee >  98%),  (2R,3S)-5  (ee  >  98%)  and  (2R,3S)-6  (ee = 50%)]
and  the  unreacted  -lactams  [(3S,4R)-1–3]  (ee  >  98%)  could  be easily  separated.
© 2015  Elsevier  B.V.  All  rights  reserved.-amino acid
. Introduction
A large number of recent published articles and reviews have
tressed the biological and chemical importance of -lactams and
-amino acids [1]. Molecules containing a 2-azetidinone ring may
ossess antibacterial activity, e.g., carumonam is a -lactamase-
esistant monobactam antibiotic [2], while others containing a cis
,4-disubstituted -lactam ring may  display PPAR / agonist [3],
asopressin VIa agonist [4] or anticancer [5,6] activity. -Amino
cids and some of their derivatives are widely used in combina-
orial, peptide, organic and medicinal chemistry [7–9]. Numerous
on-proteinogenic amino acids are available can serve as rele-
ant components of ﬁbrinogen receptor antagonists [10]. Taxol®,
ne of the most efﬁcient anticancer agents of the past decade
11,12], contains (2R,3S)-3-amino-3-phenyl-2-hydroxypropanoic
cid [(2R,3S)-7] in its side-chain. Since the total synthesis of Taxol
s a very lengthy and expensive process [13,14], chemists are con-
inuously working on the development of semi-synthetic methods
hich involve coupling of the C(13)-O of baccatin III derivatives
15] to the corresponding side-chain.
∗ Corresponding author. Fax: +36 62 545705.
E-mail address: fulop@pharm.u-szeged.hu (F. Fülöp).
ttp://dx.doi.org/10.1016/j.molcatb.2015.11.011
381-1177/© 2015 Elsevier B.V. All rights reserved.Earlier enzymatic studies on the ring opening of a set of
cyclic and acyclic -lactams [16–19] were continued with success-
ful enzymatic syntheses of a Taxol side-chain key intermediate
through the enantioselective ring opening of racemic cis-3-
hydroxy-4-phenylazetidin-2-one (0.5 equiv. of H2O in t-BuOMe at
60 ◦C, with immobilized CAL-B) and sequential kinetic resolution
of racemic cis-3-acetoxy-4-phenylazetidin-2-one (1 equiv. of H2O
in iPr2O at 60 ◦C, with immobilized CAL-B) [20]. To extend the sub-
strate scope, and also to analyse how different-sized substituents
on C3 or C4 inﬂuence the ring cleavage of -lactams, in the present
work we set out to develop immobilized CAL-B-catalysed methods
for the enzymatic ring opening of racemic 3,4-disubstituted -
lactams, such as 3-benzyloxy-4-(4-chlorophenyl) azetidin-2-one,
3-benzyloxy-4-phenylazetidin-2-one and 4-(4-chlorophenyl)-3-
phenoxyazetidin-2-one [(3S*,4R*)-(±)-1–3] (Scheme 1), and then
to synthetize (2R,3S)-3-phenylisoserine (2R,3S)-7, the key interme-
diate of the Taxol side-chain, from the corresponding enantiomeric
compound.
2. Results and discussion2.1. Synthesis of (3S*,4R*)-(±)-1–3
Racemic -lactams (3S*,4R*)-(±)-1–3 were synthesized accord-
ing to a literature method [21]. A mixture of p-ethoxyaniline
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iScheme 1. Immobilized CAL-
nd the appropriate aldehyde furnished the Schiff bases (Z)-
-(4-chlorobenzylidene)-4-ethoxybenzenamine (10) and (Z)-N-
enzylidene-4-ethoxybenzenamine (11), which, through cycload-
itions in the presence of the appropriate acyl chlorides,
-phenoxyacetyl chloride (8) or 2-benzyloxyacetyl chloride (9),
esulted in the N-protected ˇ-lactams 12–14.  CAN-mediated oxida-
ive removal of the 4-ethoxyphenyl groups gave the desired
-lactams 1–3 (Scheme 2).
.2. Immobilized CAL-B-catalysed ring-opening of
3S*,4R*)-(±)-1–3
In earlier studies, immobilized CAL-B proved to be applicable
or the enantioselective (E > 200) ring opening of both 4-aryl-
ubstituted [17] and carbocyclic -lactams [22], and we therefore
arried out the ring opening of model compound (3S*,4R*)-(±)-1
ith 1 equiv. of H2O in iPr2O at 60 ◦C, with immobilized CAL-B as
atalyst (Table 1, entry 1).
In order to ﬁnd the optimum conditions for the gram-scale res-
lution of (3S*,4R*)-(±)-1, solvent screening (Table 1, entries 1–6)
as ﬁrst performed in order to determine the effects on E and
he reaction rate. Practically, no reaction was detected during 65 h
hen the reactions were performed in THF (entry 4) or 2-Me-THF
entry 5). The reactions proceeded enantioselectively (E > 200), but
lowly in t-BuOMe and iPr2O (conv. = 5–8% after 65 h) (entries 1 and
) and with somewhat higher conversions in toluene (conv. = 15%
fter 65 h, E = 32) (entry 2) or n-hexane (conv. = 17% after 65 h,
 = 39) (entry 3). In view of the results, t-BuOMe was chosen for
urther preliminary experiments.
H2O, as a nucleophile, is essential for the ring-opening reaction,
hrough its quantity in the reaction medium can affect the enzy-
atic activity [18,22]. Experiments were therefore also performed
ith different quantities of added H2O (Table 1, entries 7–10 and
2–15). On increase of the amount of H2O up to 50 equiv., the reac-
ions became faster without a drop in E (entries 8–10), but a further
ncrease of the H2O content resulted in considerably decreases in
ClO
R1
N
R2
R3
CH2Cl2
R2
R1
TEA
8: R1 = BnO
9: R1 = PhO
10: R2 = Ph, R3 = p-EtOPh
11 R2 = p-ClPh, R3 = p-EtOPh
12: R1 = BnO
13: R1 = BnO
14: R1 = PhO
8,9 10,11 (3S*,4R
-10°C
+
Scheme 2. Synthesalysed hydrolysis of (±)-1–3.
both reaction rate and E (entries 12–15). It is noteworthy that, in
accordance with our earlier observation that a hydrolytic reaction
proceeded even without added H2O in the reaction mixture (due
to the H2O present in the reaction medium) [22], the quantity of
H2O present in the reaction medium (<0.1%) or at the surface of
the immobilized CAL-B (2–5%) was  sufﬁcient for the ring cleav-
age of (±)-1 (entry 7). Finally, 25 equiv. of H2O was  chosen as the
optimum quantity.
On increase of the temperature of the ring-opening reaction
from 60 ◦C (Table 1, entry 10) to 70 ◦C, the reaction rate increased
without any decrease in enantioselectivity (Table 1, entry 11).
Accordingly, 70 ◦C was chosen as the reaction temperature.
The above-optimized reaction conditions (25 equiv. of H2O, t-
BuOMe, 70 ◦C) were next applied for the ring cleavage of (±)-2 and
(±)-3. Excellent results were observed for (±)-2 (E > 200), but a very
poor E (5) for (±)-3 (Table 2, entry 1). We  therefore continued the
optimizations for (±)-3 with a new solvent screening, changing the
amount of added H2O and also the temperature of the reaction
(Table 2).
The reactions in toluene and n-hexane proceeded relatively
slowly, with low E (entries 2 and 3) while in MeCN and THF the
enzyme did not display activity during 65 h (entries 6 and 7).
A slightly increased E (8) was noted in iPr2O vs. tBuOMe (E = 2)
(entries 4 and 5). Variation of the quantity of water (from 2 to 100
equiv., entries 8–11) and temperature (50 and 70 ◦C, entries 12 and
13) led to the same results as observed earlier for (±)-1. In sum-
mary, E was increased slightly (E = 14, entry 13) when the reaction
was carried out with 25 equiv. of water in iPr2O at 70 ◦C (Scheme 3).
On the basis of the preliminary results, the immobilized CAL-
B-catalysed preparative-scale ring-opening reactions of (±)-1 and
(±)-2 were performed with 25 equiv. of H2O in t-BuOMe at
70 ◦C, while the preparative-scale resolution of (±)-3 was per-
formed with 25 equiv. of H2O in iPr2O at 70 ◦C. In order to obtain
(2R,3S)-6 with a good ee value, the reaction was overrun to 66%
conversion. The results are reported in Table 3 and in Section 3
(Experimental part).
N
R3
O
NH
R2
R1 O
CAN
, R2 = p-ClPh, R3 = p-EtOPh
, R2 = Ph, R3 = p-EtOPh
, R2 = p-ClPh, R3 = p-EtOPh
*)-(±)-12-14 (3S*,4R*)-(±)-1-3
MeCN
0°C
1: R1 = BnO, R2 = p-ClPh
2: R1 = BnO, R2 = Ph
3: R1 = PhO, R2 = p-ClPh
is of (±)-1–3.
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Table  1
Effects of solvents and the quantities of H2O on the immobilized CAL-B-catalysed ring cleavage of (±)-1.a
Entry Solvent H2O (equiv.) Temperature (◦C) eesb(%) eepc(%) Conv. (%) E
1 iPr2O 1 60 5 99 5 >200
2  toluene 1 60 16 93 15 32
3  n-hexane 1 60 20 94 17 39
4  THF 1 60 No reaction
5  2-Me-THF 1 60 No reaction
6  t-BuOMe 1 60 9 99 8 >200
7  t-BuOMe 0 60 5 99 5 >200
8  t-BuOMe 2 60 10 99 9 >200
9  t-BuOMe 10 60 21 99 18 >200
10  t-BuOMe 25 60 36 99 27 >200
11  t-BuOMe 25 70 54 99 35 >200
12  t-BuOMe 50 60 67 96 41 133
13  t-BuOMe 100 60 41 96 30 73
14  t-BuOMe 1850 60 45 95 32 61
15  H2O - 60 35 95 27 55
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Ia 0.015 M substrate, H2O, 30 mg  mL−1 immobilized CAL-B, after 65 h.
b According to HPLC (Section 3).
c According to HPLC after derivatization (Section 3).
.3. Synthesis of Taxol side-chain intermediate
To prepare (2R,3S)-3-amino-3-phenyl-2-hydroxypropanoic
cid [(2R,3S)-7], the key intermediate of Taxol, the debenzylation
f (2R,3S)-5  (ee = 99%) was performed in a continuous ﬂow system
H-CUBE®) by using a CatCart® ﬁlled with 10% Pd/C, operating at
 ﬂow rate of 0.1 mL/min, 50 bar, 40 ◦C (Scheme 4). Thus, (2R,3S)-7
as obtained with good ee (99%) and in nearly quantitative yield
93%) after four cycles. The absolute conﬁguration for the enan-
iomeric 7 obtained was  proved by comparing the literature [20]
˛] value for (2R,3S)-3-amino-3-phenyl-2-hydroxypropanoic acid
[˛]D25 = −7.2 (c = 0.34, H2O), ee > 99%} with the [˛] value mea-
ured for enantiomeric 7 {[˛]D25 = −7.2 (c = 0.34, H2O), ee = 99%}.
hus, immobilized CAL-B catalysed the ring opening of (3S  *,4R
)-(±)-2 with (2R,3S)  selectivity, while for (3S*,4R*)-(±)-1 and
3S*,4R*)-(±)-3 the analysed chromatograms indicated the same
nantiopreference for immobilized CAL-B.
.4. Conclusions
An efﬁcient enzymatic method was developed for the ring
pening of 3,4-disubstituted -lactams (3S*,4R*)-(±)-1–3. High
nantioselectivities (E > 200) were obtained for the ring-opening
eactions of (3S*,4R*)-(±)-1 and (3S*,4R*)-(±)-2 when immobilized
AL-B was used as catalyst, with 25 equiv. of H2O as nucleophile,
n t-BuOMe at 70 ◦C, while a relatively modest E (12) was obtained
or immobilized CAL-B-catalysed ring opening of (3S*,4R*)-(±)-3
able 2
mmobilized CAL-B-catalysed ring-opening of (±)-3.a
Entry Solvent Reaction time (h) Temperature (◦C) 
1 t-BuOMe 120 70 
2  toluene 65 60 
3  n-hexane 65 60 
4  iPr2O 65 60 
5  t-BuOMe 65 60 
6  MeCN 65 60 
7  THF 65 60 
8  iPr2O 65 60 
9  iPr2O 65 60 
10  iPr2O 65 60 
11  iPr2O 65 60 1
12  iPr2O 65 50 
13  iPr2O 65 70 
a 0.015 M substrate, H2O, 30 mg  mL−1 immobilized CAL-B.
b According to HPLC (Section 3).
c According to HPLC after derivatization (Section 3).in iPr2O with 25 equiv. of H2O at 70 ◦C. The great differences in
E for (±)-1 and (±)-2 vs. (±)-3 are presumably consequences of
the very different steric hindrance of BzO vs. PhO, which inﬂu-
ences the accommodation for the enantiomers in the active site
of immobilized CAL-B. The products could be easily separated. The
present enzymatic method proved suitable for the preparation of
(2R,3S)-3-amino-3-phenyl-2-hydroxypropanoic acid [(2R,3S)-7], a
key intermediate for the Taxol® side-chain.
3. Experimental
3.1. Materials and methods
Immobilized CAL-B (lipase B from Candida antarctica)  immo-
bilized on acrylic resin (L4777) was  purchased from Sigma.
All solvents were of the highest analytical grade. In a typ-
ical small-scale experiment, immobilized CAL-B (30 mg), then
H2O (1, 2, 10, 25, 50, 100 or 1850 equiv.) were added to
the racemic substrate (0.015 M solution) in an organic solvent
(1 mL). The mixture was shaken (167 rpm) at 50, 60 or 70 ◦C.
The progress of the reactions was followed by taking samples
from the reaction mixtures and analysing them by HPLC with a
chiral column. The ee values for the unreacted -lactams (3S,4R)-
1 and (3S,4R)-3 and the product -amino acid (2R,3S)-6 [after
pre-column derivatization [23] with CH2N2 (Caution! derivati-
zation with CH2N2 should be performed under a well-working
hood)] were determined on a Chiralpak IA column (4.6 × 250 mm);
H2O (equiv.) eesb(%) eepc(%) Conv. (%) E
25 42 55 43 5
1 7 38 15 2
1 6 53 10 3
1 8 75 10 8
1 5 37 12 2
1 No reaction
1 No reaction
2 8 75 10 8
10 38 73 34 9
25 46 72 39 10
00 70 21 76 3
25 14 78 15 9
25 81 70 54 14
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Scheme 3. Immobilized CAL
etection at 228 nm;  eluent: n-hexane/Et2N/iPA (90/0.1/10); ﬂow
ate: 0.5 mL  min−1; retention times (min) for (3S,4R)-1: 27.86
antipode: 25.51), (3S,4R)-3: 25.33 (antipode: 22.55), (2R,3S)-6:
2.43 (antipode: 27.08). (2R,3S)-4 and (2R,3S)-5 [after pre-column
erivatization with CH2N2]; Chiralpak IA column (4.6 × 250 mm);
etection at 228 nm;  eluent: n-hexane/Et2N/iPA (50/0.1/50); ﬂow
ate: 0.5 mL  min−1; retention times (min) for (2R,3S)-4: 13.80
antipode: 11.50), (2R,3S)-5: 12.36 (antipode: 10.61). (3S,4R)-2:
hiralpak IA column (4.6 × 250 mm);  detection at 228 nm;  eluent:
-hexane/Et2N/iPA (50/0.1/50); ﬂow rate: 0.5 mL  min−1; retention
imes (min) for (3S,4R)-2: 9.09 (antipode: 9.79). The ee value
or the Taxol key intermediate (2R,3S)-7 prepared was  deter-
ined by a GC method on a Chrompack Chirasil-Dex CB column
fter double derivatization [23] with (i) CH2N2; (ii) Ac2O in the
resence of 4-dimethylaminopyridine and pyridine [140 ◦C for
 min  → 190 ◦C (temperature rise 10 ◦C min−1; 100 kPa; retention
imes (min), (2R,3S)-7: 19.01 (antipode: 18.70)] (Supporting Infor-
ation S1–S7).
All melting points were measured on an X-4 melting-point
pparatus with a microscope. 1H NMR  spectra were recorded on
 Bruker Avance DRX 400 spectrometer in CDCl3 D2O and CD3OD.
0% Pd/C CatCart® was from ThalesNano (3,378 and the product ID:
HS 1,111). Optical rotations [˛] were measured with a PerkinElmer
41 polarimeter.
.2. Synthesis of 3-benzyloxy-4-(4-chlorophenyl) azetidin-2-one
(±)-1]
A solution of benzyloxyacetyl chloride (8, 0.23 mL,  1.5 mmol) in
ry CH2Cl2 was slowly added to a solution of 4-chlorobenzylidene-
-ethoxyphenylamine (11, 0.26 g, 1.0 mmol) and Et3N (0.42 mL,
.0 mmol) in CH2Cl2 (20 mL)  at −10 ◦C. The reaction was then
llowed to warm up to room heat, stirred for 12 h, washed with
aHCO3 solution (20 mL)  and brine (20 mL), then dried (Na2SO4)
nd evaporated. The product 3-benzyloxy-4-(4-chlorophenyl)-
-(4-ethoxyphenyl) azetidin-2-one (12) was recrystallized from
tOAc [265 mg,  65%; m.p. 166–168 ◦C]. A solution of CAN (0.75 g,
.4 mmol) in H2O (15 mL)  was added dropwise to the -lactam
olution (12,  0.2 g, 0.5 mmol) in MeCN (15 mL)  at 0 ◦C. The reaction
Scheme 4. Debenzylat(2R,3S)-4)-1
alysed ring opening of (±)-1.
was stirred at 0 ◦C for 30 min, 15 mL  H2O was then added and the
mixture was  extracted with EtOAc (3 × 20 mL)  and washed with
10% aqueous NaHCO3 (20 mL). The organic layer was combined
and washed with 10% Na2SO3 (2 × 15 mL), 10% NaHCO3 (10 mL),
and brine (20 mL), and dried with Na2SO4. After ﬁltration, the
solvent was  evaporated off, and the product 3-benzyloxy-4-(4-
chlorophenyl) azetidin-2-one (1) was recrystallized from EtOAc
[76 mg,  53%; m.p. 199–201 ◦C]. This product was described in 1998,
but no 1H NMR  data and m.p. were then reported [24].
1H NMR  (400 MHz, DMSO, TMS)  (ppm) for (±)-1: 4.11–4.17
(d, J = 11.64 Hz, 1H, C3H); 4.29–4.35 (d, J = 11.16); 4.86–4.90 (d,
J = 4.64 Hz, 1H, CH2); 4.93–4.98 (d, J = 4.2 Hz, 1H, CH2); 6.88–6.95
(m,  2H, Ar); 4.19–4.26 (m,  3H, Ar); 7.35–7.48 (dd, J = 8.46 Hz, 4H,
Ar); 8.63–8.69 (bs, 1H, NH). Analysis: calcd. For C16H14ClNO2: C,
66.79; H, 4.90; N, 4.87; Analysis: found for (3S*,4R*)-(±)-1: C, 66.81;
H, 4.87; N, 4.89.
3.3. Synthesis of 3-benzyloxy-4-phenylazetidin-2-one [(±)-2]
Compound 13 was prepared from benzyloxyacetyl chloride
(8, 0.23 mL,  1.5 mmol) and benzylidene-4-ethoxybenzenzamine
(10, 0.23 g, 1.0 mmol) according to the procedure described in
Section 3.2. [254 mg,  68%; m.p. 145–147 ◦C]. Removal of the 4-
ethoxyphenyl group gave the desired -lactam (±)-2 [73 mg, 58%;
m.p. 202–204 ◦C {lit [25]: m.p. = 188–189 ◦C}].
1H NMR  (400 MHz, DMSO, TMS)  (ppm) for (±)-2: 4.09–4.14
(d, J = 11,06 Hz, 1H, C3H); 4.25–4.30 (d, J = 11.44 Hz, 1H, C4H);
4.86–4.89 (d, J = 4.44 Hz, 1H, CH2); 4.93–4.96 (m,  1H, CH2);
6.84–6.89 (m,  2H, Ar); 6.85–6.89 (m,  3H, Ar); 7.33–7.41 (m, 5H, Ar);
8.61–8.67 (bs, 1H, NH). Analysis: calcd. For C16H15NO2: C, 75.87; H,
5.97; N, 5.53; Analysis: found for (3S*,4R*)-(±)-2: C, 75.89; H, 5.95;
N, 5.55.
3.4. Synthesis of 4-(4-chlorophenyl)-3-phenoxyazetidin-2-one
[(±)-3]Compound 14 was prepared from phenoxyacetyl
chloride (9, 2.07 mL, 15 mmol) and 4-chlorobenzylidene-
4-ethoxyphenylamine (11, 2.6 g, 10 mmol) according to the
ion of (2R,3S)-5.
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Table  3
Preparative-scale resolution of (±)-1a, (±)-2aand (±)-3b.
Substrate Time (h) Conv.(%) E -Lactam -Amino acid
Yield (%) Isomer eec(%) [˛]D25 Yield (%) Isomer eed(%) [˛]D25
( ± )-1 144 50 >200 35 3S,4R-1 98 −20e 30 2R,3S-4 99 +38f
( ± )-2 24 50 >200 48 3S,4R-2 98 −15g 47 2R,3S-5 99 +70h
( ± )-3 336 66 12 16 3S,4R-3 98 +45i 61 2R,3S-6 50 +11j
a 0.015 M substrate, 25 equiv. of H2O, 30 mg  mL−1 immobilized CAL-B in t-BuOMe at 70 ◦C.
b 0.015 M substrate, 25 equiv. of H2O, 30 mg  mL−1 immobilized CAL-B, in iPr2O at 70 ◦C.
c According to HPLC (Section 3).
d According to HPLC after derivatization (Section 3).
e c 0.30; CHCl3.
f c 0.10; MeOH.
g c 0.21; CHCl3.
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i c 0.21; CHCl3.
j c 0.20; MeOH.
rocedure described in Section 3.2. [2.88 g, 80%; m.p. 170k172 ◦C].
emoval of the 4-ethoxyphenyl group gave the desired -lactam
±)-3 [434 mg,  53%; m.p. 192–193 ◦C {lit [21]: m.p. = 188–190 ◦C}].
1H NMR  (400 MHz, DMSO, TMS)  (ppm) for (±)-3: 5.10–5.14
d, J = 4.6 Hz, 1H, C3H); 5.59–5.65 (dd, J = 2.12 & 4.54, 1H, C4H);
.76–6.83 (d, J = 8 Hz, 2H, Ar); 6.86–6.93 (m,  1H, Ar); 7.12–7.22 (m,
H Ar); 7.29–7.37 (m,  4H, Ar); 8.83–8.91 (bs, 1H, NH). Analysis:
alcd. For C15H12ClNO2: C, 65.82; H, 4.42; N, 5.12; Analysis: found
or (3S*,4R*)-(±)-3: C, 65.83; H, 4.40; N, 5.15.
.5. Preparative-scale resolution of racemic
-benzyloxy-4-(4-chlorophenyl) azetidin-2-one [(±)-1]
Racemic 1 (300 mg,  1.05 mmol) was dissolved in t-BuOMe
40 mL), immobilized CAL-B (2.0 g, 30 mg  mL−1) and H2O (375 L,
0.83 mmol) were added, and the mixture was  stirred at 70 ◦C
or 144 h. The reaction was stopped by ﬁltering off the enzyme
t 50% conversion. The solvent was evaporated off, affording
he unreacted -lactam (3 S,4 R)-1 {105 mg,  35%, 0.37 mmol,
e = 98%; [˛]D25 = −20 (c 0.3; CHCl3); m.p. = 188–190 ◦C}. The ﬁl-
ered immobilized CAL-B was washed with distilled H2O (3 ×
5 mL), and the H2O was evaporated off. The crystalline -amino
cid was (2R,3S)-4 {96 mg,  30%; ee = 99%; [˛]D25 = +38 (c 0.1;
eOH); m.p  = 238–240 ◦C}.
The 1H NMR  (400 MHz, DMSO, TMS)  (ppm) data for (3S,4R)-1
ere the same as those for (±)-1.
1H NMR  (400 MHz, CD3OD, TMS)  (ppm) for (2R,3S)-4:
.96–4.01 (d, J = 5.08 Hz, 1H, C2H); 4.41–4.46 (d, J = 11.6 Hz, 1H,
3H); 4.49–4.62 (d, J = 4.88 Hz, 1H, CH2) overlapping with 4.52–4.55
bs, 2H, NH2); 4.77–4.79 (s, 1H, CH2); 7.25–7.33 (m,  4H, Ar);
.37–7.46 (m,  5H, Ar). Analysis: calcd. For C16H16ClNO3: C, 62.85;
, 5.27; N, 4.58; Analysis: found for (2R,3S)-4: C, 62.87; H, 5.29; N,
.55.
.6. Preparative-scale resolution of racemic
-benzyloxy-4-phenylazetidin-2-one [(±)-2]
Racemic 2 (200 mg,  0.79 mmol) was dissolved in t-BuOMe
30 mL), immobilized CAL-B (1.5 g, 30 mg/mL) and H2O (356 L,
9.78 mmol) were added, and the mixture was  stirred at 70 ◦C for
4 h. The reaction was stopped by ﬁltering off the enzyme at 50%
onversion. The solvent was evaporated off, affording the unreacted
-lactam (3S,4R)-2 {96 mg,  48%; 0.37 mmol, ee = 98%; [˛]D25 = −15
c 0.21; CHCl3); m.p. = 192–193 ◦C}. The ﬁltered immobilized CAL-B
as washed with distilled H2O (3 × 15 mL), and the H2O was evapo-
ated off. The crystalline -amino acid was (2R,3S)-5 {101 mg,  47%;
e = 99%; [˛]D25 = +70 (c 0.3; EtOH); m.p. = 218–222 ◦C}.The 1H NMR  (400 MHz, DMSO, TMS)  (ppm) data for (3 S,4 R)-2
were the same as those for (±)-2.
1H NMR  (400 MHz, CD3OD, TMS)  (ppm) for (2 R,3 S)-5:
4.02–4.05 (d, J = 5.2 Hz, 1H, C2H); 4.41–4.46 (d, J = 11.52 Hz, 1H,
C3H); 4.49–4.52 (d, J = 8.0 Hz, 1H, CH2) overlapping with 4.51–4.54
(bs, 2H, NH2); 4.76–4.78 (s, 1H, CH2); 7.24–7.32 (m,  5H, Ar);
7.39–7.49 (m,  5H, Ar). Analysis: calcd. For C16H17NO3: C, 70.83; H,
6.32; N, 5.16; Analysi;1;;1;s: found for (2R,3S)-5: C, 70.81; H, 6.32;
N, 5.14.
3.7. Preparative-scale resolution of racemic
4-(4-chlorophenyl)-3-phenoxyazetidin-2-one [(±)-3]
Racemic 3 (200 mg,  0.73 mmol) was dissolved in iPr2O (30 mL),
immobilized CAL-B (1.5 g, 30 mg/mL) and H2O (328.5 L, 18.25
mmol) were added and the mixture was  stirred at 70 ◦C for 336 h.
The reaction was stopped by ﬁltering off the enzyme at 66% con-
version. The solvent was evaporated off, affording the unreacted
-lactam (3 S,4 R)-3 {32 mg,  16%; 0.12 mmol, ee = 98%; [˛]D25 = +45
(c 0.21; CHCl3); m.p. = 194–195 ◦C}. The ﬁltered immobilized CAL-B
was washed with distilled H2O (3 × 15 mL), and the H2O was evapo-
rated off. The crystalline -amino acid was (2R,3S)-6 {100 mg,  47%;
ee = 50%; [˛]D25 = +11 (c 0.2; MeOH); m.p. = 250–258 ◦C}.
The 1H NMR  (400 MHz, DMSO, TMS)  (ppm) data for (3S,4R)-3
were the same as those for (±)-3.
1H NMR  (400 MHz, CD3OD, TMS)  (ppm) for (2R,3S)-6:
4.51–4.56 (s, 2H, NH2); 4.65–4.70 (m,  2H, C3H, C4H); 6.92–7.05
(m,  3H, Ar); 7.21–7.30 (m,  2H, Ar); 7.41–7.55 (m, 4H, Ar). Analysis:
calcd. For C15H14ClNO3: C, 61.76; H, 4.84; N, 4.80; Analysis: found
for (2R,3S)-6: C, 61.76; H, 4.86; N, 4.82.
3.8. Debenzylation of (2 R, 3 S)-5
The debenzylation was carried out in a continuous ﬂow system.
(2R,3S)-5 (17 mg)  was dissolved in MeOH (20 mL), and the solu-
tion was  pumped through the compressed and heated 10% Pd/C
cartridge at a ﬂow rate of 0.1 mL  min−1. The pressure was 50 bar,
the temperature 40 ◦C and the H-CUBE system was in ‘Hydrogen’
mode. After four cycles, the solvent was evaporated off. (2R,3S)-
7 {11 mg,  97%; ee = 99%; [˛]D25 = −7.1 (c 0.34; H2O)} these data
being approximately equivalent to the literature [20] [˛] data for
(3S,4R)-5 {ee = 99%; [˛]D25 = −7.2 (c 0.34; H2O)}.
1H NMR  (400 MHz, D2O, TMS)  (ppm) for (2R,3S)-7: 4.31–4.37
[d, J = 5.9 Hz, 1H, CH (OH)(COOH)], 4.55–4.60 (d, J = 5.9 Hz, 1H,
CHNH2), 7.40–7.55 (m,  5H, C6H5). Analysis: calcd. For C9H11NO3:
C, 59.66; H, 6.12; N, 7.73; Analysis: found for (2R,3S)-7: C, 59.69; H,
6.10; N, 7.73.
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